In China, Chinese medicines and their active ingredients have been widely used to treat lung cancer including TKI-resistant NSCLC18,41-45, and some of them have shown a synergistic inhibitory effect and lower TKIs resistance in EGFR L858R+T790M-Mutated H1975 Cells 18,32-35. Here, EGFR is linked to lung carcinoma.